MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Hunter Syndrome

  1. Home
  2. Diseases
  3. Hunter Syndrome
  4. Clinical Trials

Clinical Trials Related to Hunter Syndrome

Related studies linked through entity extraction aliases.

NCT01043640

Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders

Status
COMPLETED
Phase
PHASE2

NCT00937794

Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase®

Status
COMPLETED
Phase
N/A

NCT00920647

A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®

Status
COMPLETED
Phase
PHASE1/PHASE2

NCT00882921

An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients

Status
COMPLETED
Phase
N/A

NCT00630747

Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase

Status
COMPLETED
Phase
PHASE2/PHASE3

NCT00607386

Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy

Status
COMPLETED
Phase
PHASE4
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.